Walmart escapes major legal penalty for a fraction of the cost

Walmart has concluded a significant legal battle that once posed a severe threat, settling for a relatively modest sum of $50 million. The resolution came after five years of uncertainty, which saw the company facing potential penalties of up to $67,627 per unlawful prescription and $15,691 for each unreported suspicious order. On August 28, the Justice Department and the Drug Enforcement Administration announced the settlement, with Walmart admitting no wrongdoing.

The case originated from claims that Walmart's pharmacies filled thousands of invalid opioid prescriptions, but U.S. District Judge Colm Connolly dismissed many allegations in March 2024, ultimately leading to the settlement. The opioid crisis has been a major concern for authorities, with over 500,000 deaths from opioid overdoses between 1999 and 2019.

Walmart's settlement of $50 million represents a mere 0.4% of its half-year profit, making the financial impact relatively insignificant. By settling, the company eliminated the uncertainty and potential financial burden of a lengthy trial, allowing investors to focus on Walmart's ongoing challenges, such as slowing U.S. comparable sales.